OpGen Group Company Ares Genetics Demonstrates Feasibility of CLIA-compliant Next Generation Sequencing Workflow for Identification of Bacterial Pathogens and Antibiotic Resistance Markers

NASDAQ Market News

NEXT STORY
BridgeBio Pharma Expands Reach Into China and Other Major Asian Markets Through Strategic Collaboration With Perceptive Advisors-Founded Company, LianBio
PREV STORY
Pulmonary Devices Market Forecast to 2027 – COVID-19 Impact and Global Analysis by Type ; Application ; End User, and Geography
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

UPDATE — Mateon Therapeutics to Present New Improved Survival Outcomes for CA4P in Recurrent Ovarian Cancer at June 27 Investor Event

Updated data shows improvement in overall survival of 3.2 months for all CA4P-treated patients ...

author_avatar
NASDAQ Market News

Chi-Med Announces that Surufatinib Phase III SANET-p Study Has Already Achieved its Primary Endpoint in Advanced Pancreatic Neuroendocrine Tumors in China and Will Stop Early

author_avatar
NASDAQ Market News

Summit Therapeutics Reports Financial Results and Operational Progress for the First Quarter Ended March 31, 2021

author_avatar
NASDAQ Market News